STUDY OF CROSS-ACTIVITY OF STREPTOCOCCUS PNEUMONIAE ANTIGEN PREPARATIONS
- Authors: Vaneeva NP1, Vorob'ev DS1, Grishchenko NV1, Kurbatova EA1, Yastrebova NE1, Kalina NG1, Elkina SI1, Zubkov AV1, Aparin PG1, L'vov VL1, Mikhaylova NA1
-
Affiliations:
- Issue: Vol 89, No 5 (2012)
- Pages: 36-42
- Section: Articles
- Submitted: 13.06.2023
- Published: 15.10.2012
- URL: https://microbiol.crie.ru/jour/article/view/14186
- ID: 14186
Cite item
Full Text
Abstract
were obtained by ultrasound disintegration (from bacteria in R-form), extraction with water (from
serotype 3 bacteria), cetavlon and trichloroacetic acid (from serotype 6A bacteria). Chemical composition
and immunochemic properties of preparations were studied by contemporary methods as well as in experiments
with direct and cross-protection of mice from infection. Results. 3 of 4 preparations (except ultrasound
disintegrate) had approximately 30% of protein. In immunodiffusion reaction they interacted with hyper
immune rabbit sera obtained against 12 various pneumococcus serotypes - 1, 3, 4, 6А, 6В, 9V, 9N, 14, 18C,
19A, 19F and 23F. In animal experiments 30 - 70% of mice were protected from subsequent infection with
knowingly high dose of homologous and 3 heterologous pneumococcus strains. In immunoblotting the highest
number of components serologically active with heterologous sera was formed by cetavlon extract (12
- 23). Addition of capsule polysaccharides to the preparation increased its cross-protective activity. Conclusion.
By data set and the highest yield, water extract is reasonable for isolation of cross-reactive proteins of pneumococcus.
Development of another method of extraction from cultural fluid is necessary for obtaining extracellular
protein antigens. Generation of vaccines containing cross-reactive proteins of pneumococcus and
capsule polysaccharides is a promising direction.
Keywords
About the authors
N P Vaneeva
D S Vorob'ev
N V Grishchenko
E A Kurbatova
N E Yastrebova
N G Kalina
S I Elkina
A V Zubkov
P G Aparin
V L L'vov
N A Mikhaylova
References
- Арчибальд А.Р. Тейхоевые кислоты. В: Методы исследования углеводов. М., 1975.
- Беседнова Н.Н., Запорожец Т.С. Действие дезоксирибонуклеиновой кислоты прокариот на гуморальные и клеточные факторы врожденного и адаптивного иммунитета позвоночyых. Тихоокеанский мед..журнал. 2009, 3: 8-12.
- Ефремова В.Е., Егорова Н.Б. Токсичность и протективная активность комплексного антигена стафилококка, полученного методом водной экстракции. Журн.микробиол. 1978, 12: 59-63.
- Иммунологические методы. Г.Фримель (ред.). М., Медицина, 1987.
- Михайлов А.Т., Симирский В.А. Методы иммунохимического анализа в биологии развития. М., Наука. 1991.
- Падюков Л.Н. Вакцина против пневмококковой инфекции. Патент РФ № 2087156. 1997.
- Baddiley J. Teichoic acid in walls and cells of grampositive bacteria. Fed. Proc. 1962, 21: 1084-1088.
- Dubois K., Gillers K.A., Hamilton J.K. et al. Colorimetric method for the determination of sugars. Anal. Chem. 1956, 28: 350-354.
- Fine D.P. Pneumococcal type-associated variability in alternate complement pathway activation. Infect.Immun. 1975, 12: 772-778.
- Gotschlich E.C., Liu T.G., Artenstein M.C. Human immunity to the meningococcus III Preparation and immunochemical properties of the group A, group B and group C at meningococcal polysaccharidis. Exp.Med. 1969, 129 (6): 1349-1365.
- Jedrzejas M.J. Pneumococcal virulence factors: structure and function. Microbiol. Mol. Biol. Pev. 2001, 65 (2): 187-207.
- Lawrell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel, containing antibodies. Analit.Biochem. 1966, 11: 45-49.
- Lowry O.H., Rosebrought N.F., Farr A.L., Handale R.I. Protein measurement with the Folin-reagent. J. Biol. Chem. 1951, 193: 265-271.
- Lu Y.J., Forte S., Thompson C.M. et al. Protection against pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide. Infect. Immun. 2009, 77 (5): 2076-2083.
- Meng C.,. Lin H., Huang J. et al. Development of 5-valent conjugate pneumococcal protein A-capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. Microb. Pathog. 2009, 47: 151-156.
- Ogunniyi A.D., Grabowicz M., Briles D.E. et al. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 2001, 75 (1): 350-357.
- Oliveiro M., Miyaji E., Ferreira D. et al. Combination of Pneumococcal surface protein A (Psp A) with whole cell Pertussis vaccine increases protection against pneumococcal challenge in mice. J. PLOS ONE. 2010, 5 (5): 10863.
- Ouchterlony O. In vitro method for testing the toxin producing capacity of diphteriae bacteria. Act a Path. Microb. Scand. 1946, 25: 185-191.
- Pneumococcal vaccine the impact of conjugate vaccine. G.R. Siber, K.P. Klugman, P.H. Makela (ed.). ASM Press, 2008.
- Tai S.S. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 2006, 32 (3): 139-153.
- Talaga P., Moreau M. Quantification of C-polysaccharide in Streptococcus pneumoniae polysaccharides by high-perfomance anion-exchange chromatography with pulsed amperometric detection.
- F. Brown, M. Corbel, E. Griffiths (ed.) . Dev. Biol. Basel, Karger. 2000, 103: 27-34.
- Walley M.J., Sampson J.S., Johnson S.E. et al. Concomitant administrstion of recombinant Psa A and PCV 7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model. J. Vaccine. 2010, 28: 3071-3075.
- Wong K.H., Barrera O., Sutton A. et al. Standartization and control of meningococcal vaccines group A and group C polysaccharides. J. Biol. Stand. 1977, 5: 197-215.